Sylvester Comprehensive Cancer Center/X
Jul 24, 2024, 22:05
‘FLAGSHIP’ study opened at Sylvester Comprehensive Cancer Center’s Myeloma Institute
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Exciting ‘FLAGSHIP’ study opened at Sylvester Comprehensive Cancer Center’s Myeloma Institute in Miami!
Collaboration with Boston Gene for exact molecular sub-typing and personalized treatment strategies.
See here.“
Source: C. Ola Landgren/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 14:54
Aug 10, 2025, 13:44
Aug 10, 2025, 12:46
Aug 10, 2025, 12:39
Aug 10, 2025, 12:29